Tag: Pharma

The Expo that will go live from 22nd to 25th Septmeber has a series of interesting webinars and panel discussions on Medical Device, Bio-Pharma Manufacturing, Vaccines, Testing and much more. Participation of 50 exhibitors and 2,000 visitors is expected during the 4 days of the program...................

15%-20% of healthcare is expected to shift to virtual care, across triaging, consults, remote monitoring and home health. 64% of surveyed consumers are willing to adopt teleconsultation post COVID-19.......................

A key finding of the study is that nearly 80% of the 619 healthcare practitioners surveyed from around the country incorrectly believe that it is the nicotine in tobacco products that causes cancer........................

Blue Cross’ new digital campaign led by C Com Digital highlights the need for affordable medicines and compassion towards people during the pandemic. The video drives home the message that with Blue Cross people with certain health conditions can now get their medication at almost 60% less cost..................

In an effort to strengthen their the biosimilar product portfolio, Cadalimab™ is the fourth biosimilar launched in the last 2 months by Cadila Pharmaceuticals..................

The integrated program encompasses formulation development, drug substances and drug product manufacturing. The project involves three Piramal Pharma Solutions (PPS) sites in India......................

In the wake of COVID-19, pharma marketing is embracing digitization. India’s share in world’s vaccine production is 50%, making it the largest supplier.....................

In India, SCHOTT’s 50-50 joint venture, SCHOTT KAISHA is supplying vials for COVID-19 vaccines to Serum Institute (India) and several other players...............

Biosimilar Rituximab is used for the treatment of blood cancer and rheumatoid arthritis and will be launched under the brand name Ritucad™......................

Cipla Limited has announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.................